3647 results for «686»

Filter By

3647 results

Calcification clinical cases

04 Mar 2023 – From AfricaPCR 2023

Learn more about transcatheter lithotripsy for aortic subvalvar calcification or LIMA and left anterior descending perforation in this session dedicated to calcification which includes 5 different clinical cases.

Calcification clinical cases

Matching patient to TAVI prosthesis - Is there a better way?

04 Mar 2023 – From AfricaPCR 2023

In this AfricaPCR 2023 session, analyse several complex TAVI cases and explore why and how THV design elements should help optimise TAVI clinical outcomes.

Matching patient to TAVI prosthesis - Is there a better way?

AfricaPCR 2023: Opening Ceremony

03 Mar 2023 – From AfricaPCR 2023

After 3 years without a physical Course, it is with great pleasure that the speakers open this new edition of AfricaPCR. They begin by recalling the values of this Course and presenting its Directors, then they unfold the programme by underlining the strong points and also...

AfricaPCR 2023: Opening Ceremony

AfricaPCR 2023: Closing Ceremony

04 Mar 2023 – From AfricaPCR 2023

Beyond all the thanks that should naturally be expressed at the time of closing this new edition of AfricaPCR, this closing ceremony is also an opportunity to remind that the contents of this course remain available on our platforms and social networks, and that the appointment...

AfricaPCR 2023: Closing Ceremony

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial

26 Aug 2023

Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.

BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

Nicola Ryan

Author

Nicola Ryan
BIOFLOW DAPT - Biodegradable polymer SES vs durable polymer ZES in HBR subjects with 1-month DAPT
Didn’t find what you were looking for?